MedPage Today on MSN1d
Pembrolizumab-CRT: The New Standard of Care in Locally Advanced Cervical Cancer?A pembrolizumab (Keytruda) combination led to an overall survival (OS) boost in patients with newly diagnosed, previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback